These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


299 related items for PubMed ID: 11510266

  • 21. Nutritional status and efficiency of dialysis in CAPD and CCPD patients.
    Abdo F, Clemente L, Davy J, Grant J, Ladouceur D, Morton AR.
    Adv Perit Dial; 1993; 9():76-9. PubMed ID: 8105968
    [Abstract] [Full Text] [Related]

  • 22. The outcome for pediatric patients on peritoneal dialysis.
    Acar B, Yalcinkaya F, Cakar N, Yüksel S, Ozçakar ZB, Uncu N, Kara N, Elhan AH, Ekim M.
    J Nephrol; 2008; 21(3):394-9. PubMed ID: 18587728
    [Abstract] [Full Text] [Related]

  • 23. Infrequent dosing of subcutaneous erythropoietin for the treatment of anemia in patients on CAPD.
    Bunke M, Bartlett DK, Brier ME, Golper TA.
    Adv Perit Dial; 1993; 9():331-5. PubMed ID: 8105957
    [Abstract] [Full Text] [Related]

  • 24. Effects of human recombinant erythropoietin on inflammatory status in peritoneal dialysis patients.
    Aguilera A, Bajo MA, Díez JJ, Ruiz-Caravaca ML, Vicenta Cuesta M, Alvarez V, Codoceo R, Selgas R.
    Adv Perit Dial; 2002; 18():200-5. PubMed ID: 12402619
    [Abstract] [Full Text] [Related]

  • 25. Impact of elevated C-reactive protein levels on erythropoiesis- stimulating agent (ESA) dose and responsiveness in hemodialysis patients.
    Bradbury BD, Critchlow CW, Weir MR, Stewart R, Krishnan M, Hakim RH.
    Nephrol Dial Transplant; 2009 Mar; 24(3):919-25. PubMed ID: 18840893
    [Abstract] [Full Text] [Related]

  • 26. Factors related to erythropoietin hypo-responsiveness in patients on chronic peritoneal dialysis.
    Wei M, Bargman JM, Oreopoulos DG.
    Int Urol Nephrol; 2007 Mar; 39(3):935-40. PubMed ID: 17534732
    [Abstract] [Full Text] [Related]

  • 27. Influence of peritoneal transfer status on fasting blood glucose in non-diabetic nephropathy patients on continuous ambulatory peritoneal dialysis.
    Yu XF, Zhou YF, Feng L, Zhang DL, Liu WH.
    Chin Med J (Engl); 2009 Dec 20; 122(24):2977-80. PubMed ID: 20137485
    [Abstract] [Full Text] [Related]

  • 28. Drain volume required for a target peritoneal clearance: formulae based on peritoneal transport type and body size.
    Tzamaloukas AH, Malhotra D, Murata GH.
    ASAIO J; 1998 Dec 20; 44(6):828-34. PubMed ID: 9831093
    [Abstract] [Full Text] [Related]

  • 29. Recombinant human erythropoietin (rHuEPO) therapy has no effect on peritoneal transport in CAPD patients: a short-term study.
    Wong PN, Mak SK, Lo KY, Tong GM, Wong AK.
    Adv Perit Dial; 1998 Dec 20; 14():11-3. PubMed ID: 10649682
    [Abstract] [Full Text] [Related]

  • 30. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL, Moles K, Pope K, Hargrove P.
    Adv Perit Dial; 1999 Dec 20; 15():60-4. PubMed ID: 10682073
    [Abstract] [Full Text] [Related]

  • 31. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H, Wang SX.
    Blood Purif; 2008 Dec 20; 26(2):151-6. PubMed ID: 18212498
    [Abstract] [Full Text] [Related]

  • 32. Low serum albumin in elderly continuous ambulatory peritoneal dialysis patients is attributable to high permeability of peritoneum.
    Nakamoto H, Imai H, Kawanishi H, Nakamoto M, Minakuchi J, Kumon S, Watanabe S, Shiohira Y, Ishii T, Kawahara T, Suzuki H.
    Adv Perit Dial; 2001 Dec 20; 17():238-43. PubMed ID: 11510284
    [Abstract] [Full Text] [Related]

  • 33. Medium term response to H-R erythropoietin in CAPD patients: the influence of erythropoietin plasmatic levels and the effects on peritoneal transport capacity.
    Bajo MA, Selgas R, Miranda B, Fernandez-Zamorano A, Borrego F, Romero JR, Caparros G, Riñon C, Sanchez Sicilia L.
    Adv Perit Dial; 1991 Dec 20; 7():296-300. PubMed ID: 1680450
    [Abstract] [Full Text] [Related]

  • 34. Association between C-reactive protein and clinical outcomes in peritoneal dialysis patients.
    Avram MM, Fein PA, Paluch MM, Schloth T, Chattopadhyay J.
    Adv Perit Dial; 2005 Dec 20; 21():154-8. PubMed ID: 16686309
    [Abstract] [Full Text] [Related]

  • 35. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
    El-Khatib M, Duncan HJ, Kant KS.
    Nephrology (Carlton); 2006 Oct 20; 11(5):400-4. PubMed ID: 17014552
    [Abstract] [Full Text] [Related]

  • 36. Peritoneal protein losses in diabetic patients starting peritoneal dialysis: is there a relationship with diabetic vascular lesions?
    Coronel F, Cigarrán S, Herrero JA, Delgado J, Ramos F, Gomis A.
    Adv Perit Dial; 2009 Oct 20; 25():115-8. PubMed ID: 19886331
    [Abstract] [Full Text] [Related]

  • 37. Malnutrition-inflammation syndrome is associated with endothelial dysfunction in peritoneal dialysis patients.
    Aguilera A, Sánchez-Tomero JA, Bajo MA, Ruiz-Caravaca ML, Alvarez V, del Peso G, Herranz A, Cuesta MV, Castro MJ, Selgas R.
    Adv Perit Dial; 2003 Oct 20; 19():240-5. PubMed ID: 14763071
    [Abstract] [Full Text] [Related]

  • 38. The relationship between reticulocyte hemoglobin content with C-reactive protein and conventional iron parameters in dialysis patients.
    Hackeng CM, Beerenhout CM, Hermans M, Van der Kuy PH, Van der Dussen H, Van Dieijen-Visser MP, Hamulyák K, Van der Sande FM, Leunissen KM, Kooman JP.
    J Nephrol; 2004 Oct 20; 17(1):107-11. PubMed ID: 15151266
    [Abstract] [Full Text] [Related]

  • 39. Usefulness of the dialysis adequacy and transport test in peritoneal dialysis.
    Seo JJ, Kim YL, Park SH, Kim CD, Kim JC, Jang MH, Choi HJ.
    Adv Perit Dial; 2005 Oct 20; 21():25-30. PubMed ID: 16686280
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up.
    Clerbaux G, Francart J, Wallemacq P, Robert A, Goffin E.
    Nephrol Dial Transplant; 2006 Apr 20; 21(4):1032-9. PubMed ID: 16364990
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.